Currently, at least 24 bills in nine states focus on transgender patients, and four states in 2023 have legalized restrictions on gender-affirming care.

A coalition of 22 states argues that the vaccine mandate has intensified workforce shortages at health care facilities and limited patient access to care.

Ten states and the District of Columbia no longer report their COVID-19 data on a daily basis.

At least 20 states are pursuing legislation to limit access to gender-affirming care for transgender youth, while some states have proposed legislation to prohibit discrimination based on sexual orientation and gender identity.

The Federal Emergency Management Agency is supporting vaccination sites in 19 states and U.S. territories. States vary in their approaches to distribute COVID-19 vaccines to children; some are prioritizing subpopulations of children while others are involving child health stakeholders in planning.

Under the proposed Section 1115 waiver, Oklahoma would accept a per-capita cap on federal funds for the Medicaid expansion population and incorporate other market-based reforms.

Oklahoma claims that Purdue Pharma and two other pharmaceutical companies understated the benefits and risks of prescription opioids; Purdue has agreed to pay $270 million to settle its part in the lawsuit.